1 Hahn BHSingh RPLa Cava A . Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.J Immunol2005; 175: 7728 – 7737 .
2.
2 Ferrera FHahn BRizzi M . Somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide protects (NZB × NZW)F1 lupus-prone mice from renal disease.Arthritis Rheum2007 [in press].
3.
3 Singh RLa Cava AEbling F . Induction of immune tolerance with a consensus peptide induces CD8+ inhibitory T cells that depend on Foxp3 expression for function.J Immunol2007 [in press].
4.
4 Gaipl USBeyer TDHeyder P . Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin.Arthritis Rheum2004; 50: 640 – 649 .
5.
5 Wellmann ULetz MHerrmann M . The evolution of human anti-double-stranded DNA autoantibodies.Proc Natl Acad Sci U S A2005; 102: 9258 – 9263 .
6.
6 Kuhn AHerrmann MKleber S . Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation.Arthritis Rheum2006; 54: 939 – 950 .
7.
7 Yachimovich NMostoslavsky GYarkoni Y . The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.Eur J Immunol2002; 32: 1164 – 1174 .
8.
8 Yachimovich-Cohen NFischel RBachar N . Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.Eur J Immunol2003; 33: 2469 – 2478 .
9.
9 Yarkoni YFischel RKat I . Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice.Eur J Immunol2006; 36: 2755 – 2767 .
10.
10 Bensimon CChastagner PZouali M . Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements.Embo J1994; 13: 2951 – 2962 .
11.
11 Suzuki NHarada TMihara S . Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.J Clin Invest1996; 98: 1843 – 1850 .
12.
12 Mazari LOuarzane MZouali M . Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus.Proc Natl Acad Sci U S A2007; 104: 6317 – 6322 .
13.
13 Zouali MSarmay G . B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.Arthritis Rheum2004; 50: 2730 – 2741 .
14.
14 Hasler PZouali M . B cell receptor signaling and autoimmunity.Faseb J2001; 15: 2085 – 2098 .
15.
15 Jury ECKabouridis PSAbba A . Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.Arthritis Rheum2003; 48: 1343 – 1354 .
16.
16 Jury ECKabouridis PSFlores-Borja F . Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.J Clin Invest2004; 113: 1176 – 1187 .
17.
17 Flores-Borja FKabouridis PSJury EC . Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.Arthritis Rheum2005; 52: 3955 – 3965 .
18.
18 Flores-Borja FKabouridis PSJury EC . Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus.Arthritis Rheum2007; 56: 291 – 302 .
19.
19 Gauld SBBenschop RJMerrell KT . Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.Nat Immunol2005; 6: 1160 – 1167 .
20.
20 Johnson KGBromley SKDustin ML . A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation.Proc Natl Acad Sci U S A2000; 97: 10,138 – 10,143 .